How war propelled tissue repair startup to global success
The October 7 attacks unintentionally made MediWound the primary burn treatment in Israel. Now, the company plans to tackle diabetic foot ulcers.
The October 7 attacks unintentionally made MediWound the primary burn treatment in Israel. Now, the company plans to tackle diabetic foot ulcers.
As part of our 20th anniversary celebration, we find out what happened to some of the most promising startups we featured in our early days.
Biomedical Advanced Research and Development Authority of the US Dept. of Health and Human Services chooses NexoBrid to build national preparedness.
Valued at up to $112 million, the government contract positions NexoBrid as a tool for mass casualty preparedness in the United States.